Nuclear medicine item 61485 - One-off schedule fee increase

From 1 November 2023 an increase to the schedule fee for MBS item 61485 from $999.20 to $3,364.00 will occur. The new fee will more appropriately cover the cost of the radiopharmaceutical administered as part of the service. The changes are being made to ensure that therapeutic nuclear services provided under the MBS are up to date and support ongoing patient access. The increase to the schedule fee for item 61485 was recommended by the MBS Review Taskforce.

Further information can be found in the factsheet below:

PDF Version Nuclear medicine item 61485 - One-off schedule fee increase (PDF 178 KB)
Word Version Nuclear medicine item 61485 - One-off schedule fee increase (Word 121 KB)